Analysis of DRAM-related proteins reveals evolutionarily conserved and divergent roles in the control of autophagy by O'Prey, Jim et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analysis of DRAM-related proteins reveals evolutionarily
conserved and divergent roles in the control of autophagy
Citation for published version:
O'Prey, J, Skommer, J, Wilkinson, S & Ryan, KM 2009, 'Analysis of DRAM-related proteins reveals
evolutionarily conserved and divergent roles in the control of autophagy' Cell Cycle, vol. 8, no. 14, pp. 2260-
5.
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Cell Cycle
Publisher Rights Statement:
Landes Bioscience open access
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
[Cell Cycle 8:14, 2260-2265; 15 July 2009]; ©2009 Landes Bioscience
2260 Cell Cycle 2009; Vol. 8 Issue 14
Autophagy is a membrane-trafficking process that serves 
to deliver cytoplasmic proteins and organelles to the lyso-
some for degradation. The process is genetically defined and 
many of the factors involved are conserved from yeast to man. 
Recently, a number of new autophagy regulators have been 
defined, including the Damage-Regulated Autophagy Modulator 
(DRAM), which is a lysosomal protein that links autophagy and 
the tumor suppressor, p53. We describe here analysis of DRAM-
related proteins which reveals evolutionary conservation and 
divergence of DRAM’s role in autophagy. We report that humans 
have 5 other proteins that show significant homology to DRAM. 
The closest of these, which we have termed DRAM2, displays 
45% identity and 67% conservation when compared to DRAM. 
Interestingly, although similar to DRAM in terms of homology, 
DRAM2 is different from DRAM as it not induced by p53 or p73. 
DRAM2 is also a lysosomal protein, but again unlike DRAM its 
overexpression does not modulate autophagy. In contrast to 
humans, the Drosophila genome only encodes one DRAM-like 
protein, which is approximately equal in similarity to human 
DRAM and DRAM2. This questions, therefore, whether DRAM 
function is conserved from fly to man or whether DRAM’s 
capacity to regulate autophagy has evolved in higher eukaryotes. 
Expression of DmDRAM, however, clearly revealed an ability to 
modulate autophagy. This points, therefore, to a conserved role 
of DRAM in this process and that additional human proteins 
have more recently evolved which, while potentially sharing some 
similarities with DRAM, may not be as intrinsically connected to 
autophagy regulation.
Introduction
Macroautophagy (hereafter referred to as autophagy) is an 
 evolutionarily conserved membrane trafficking process that effects 
the lysosomal degradation of cytoplasmic proteins and is the only 
mechanism for the degradation of organelles.1,2 At induction, 
membrane structures termed ‘isolation membranes’ originate within 
the cytoplasm of the cell. These membranes then grow and mature 
to form double-membrane vesicles (autophagosomes) which encap-
sulate the cellular cargos destined for degradation.1 Autophagosomes 
can then undergo fusion events with multi-vesicular bodies and 
endosomes, but ultimately fusion occurs with lysosomes to form 
‘autolysosomes’. The acidic hydrolases provided by the lysosome 
then effect the degradation of the contents of the autolysosome 
resulting in the formation of constituent parts of the cargo, e.g., 
amino acids and fatty acids.3 These factors can then undergo further 
catabolic breakdown or can be recycled into biosynthetic pathways.
Although active under basal conditions as a means to monitor the 
integrity of long-lived proteins and organelles, the rate and cargo of 
autophagy can change in response to various forms of cellular stress. 
In response to catabolic defects or nutrient deprivation, autophagy 
can be activated to degrade cellular components as a self-limited cell 
survival mechanism which can then be used for the generation of 
ATP until nutrient replete conditions are regained.4-6 Under other 
forms of cellular stress, autophagy can be activated to promote cell 
survival by the removal of damaged or misfolded proteins and organ-
elles, which, if not removed, would compromise cell viability.7,8
As well as promoting cell survival, a number of other reports 
have also indicated that autophagy is a component of pro-death 
mechanisms.9-11 In addition, while the cell survival aspects of 
autophagy could clearly be considered oncogenic, there is signifi-
cant evidence that autophagy is inactivated in human cancer 
indicating a tumor suppressive role.12-14 In line with this, mouse 
models where autophagic factors have been compromised have 
been reported to be tumor prone.15-17
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Despite the disparate functions of autophagy, the core process 
is mediated by a series of ‘Atg’ genes which in most cases are 
clearly conserved from yeast to man.1,2,18 More recently, however, 
a number of additional autophagy regulators have been described 
which in some cases function in selective autophagy scenarios, 
but little is known of their evolutionary nature. One such factor 
is the Damage-Regulated Autophagy Modulator, DRAM, which 
was the first molecular link to be reported between autophagy 
regulation and the tumor suppressor p53.19,20 At basal levels 
p53 has been shown to act as a suppressor of autophagy through 
protein-protein interactions at mitochondria.21,22 In response to 
various forms of cellular stress, however, the levels of p53 become 
elevated and the majority of p53 translocates to the nucleus where 
it promotes the transactivation of a broad spectrum of target 
genes that mediate p53’s tumor suppressive effects.23 One of the 
genes activated by p53 is DRAM which is required for the ability 
of p53 to induce autophagy and is also critical for the ability of 
p53 to induce programmed cell death.19,20 Since autophagy, but 
not p53, is present in yeast, we questioned the nature of DRAM’s 
evolutionary conservation. This revealed that there are five human 
proteins that show significant homology to DRAM, but in simpler 
organisms such as Drosophila there is only one, DmDRAM. We 
present here the comparative analysis of DRAM, DmDRAM and 
DRAM2—the most closely related human protein to DRAM. 
These studies reveal insights into the conserved and yet divergent 
roles of DRAM protein in autophagy regulation.
Results and Discussion
Humans contain a family of DRAM proteins. In order to 
gain insight into the evolutionary nature of DRAM, BLAST 
searches were undertaken for human proteins which share signifi-
cant homology to the DRAM peptide sequence. This resulted 
in the identification five previously undescribed human proteins 
that were similar to DRAM, indicating that DRAM belongs to 
an uncharacterized protein family. Phylogenetic analysis of these 
proteins revealed varying degrees of relatedness to DRAM and as 
a result we nominally refer to these proteins as DRAM2 through 
DRAM4, DRAM5a and DRAM5b (the last two proteins are 
isoforms from the same gene) (Fig. 1A). DRAM2 is by far the most 
closely related human protein to DRAM and shares 45% identity 
and 67% conservation at the amino acid level (Fig. 1B). Different 
to DRAM, however, which is undetectable by northern analysis 
in unstressed cells, DRAM2 expression was clearly detectable in a 
number of tissues. Expression was highest in placenta and heart, 
although most tissues exhibited some level of expression, with only 
brain and thymus seemingly devoid of detectable mRNA expres-
sion.
DRAM2 is biologically distinct from DRAM. Since DRAM2 
is so closely related to DRAM, we decided to investigate if 
DRAM2 was also like DRAM biologically. Firstly, since expres-
sion of DRAM is known to be induced by p53 and its related 
family member p73,19,24 we sought to determine if DRAM2 was 
Regulation of autophagy by DRAM related proteins
Figure 1. DRAM2/TMEM77 is the closest of a family of DRAM-related proteins. (A) A search for DRAM-related human proteins by BLAST revealed 
5 proteins that have significant homology to DRAM at the protein level. (B) Line-up of the peptide sequences of DRAM and DRAM2/TMEM77. (C) 
Northern blot of DRAM2 expression in human tissues. Previous designations and accession numbers of DRAM family proteins are: DRAM2—TMEM77 
(NP_848549.3); DRAM3—TMEM224 (NP_001078957.1); DRAM4—LOC441027/FLJ12993 (NP_001073975.1); DRAM5a—TMEM150/FLJ90024 
isoform 1 (NP_001026908.1); DRAM5b—TMEM150/FLJ90024 isoform 2 (NP_669173.1).
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as previously described. Cells were then fixed and stained with 
an antibody against the lysosomal protein, cathepsin D. Indeed, 
similar to DRAM,19 DRAM2 was clearly co-compartmentalized 
with cathepsin D (Fig. 3A) indicating that DRAM2, as a result 
of regions of hydrophobicity in its peptide sequence (Fig. 1B), is 
most likely a lysosomal membrane protein. No co-localization was 
observed with other markers of sub-cellular compartments (data 
not shown).
TetOn-DRAM and TetOn-DRAM2 cells were then infected 
with an adenovirus expressing GFP-LC3 (a marker of autophago-
somes) which changes from a diffuse cytoplasmic localization to 
a more punctate pattern as the LC3 integrates in autophagosome 
membranes upon their formation.25,26 Following treatment of 
these cells with Dox for a period of 24 h, the cells were stained 
for DRAM/DRAM2 expression and the formation of autopha-
gosomes assessed by fluorescent microscopy. In agreement with 
previous reports, induction of DRAM caused clear accumulation 
of autophagosomes (Fig. 3B).19 No increase in autophagosomes 
was observed, however, as a result of DRAM2 induction (Fig. 3B) 
despite similar levels of protein expression being observed by 
western blotting (Fig. 2A). This result was confirmed in long-lived 
protein assays—which are a measure of autophagic flux—in which 
also induced by these two tumor suppressive transcription factors. 
Due to the similarity between the mRNA sequences of DRAM 
and DRAM2, qPCR primers were generated and first tested for 
specificity in TetOn inducible cell lines for DRAM and DRAM2 
(Fig. 2A–C). These primers were then used to assess the relative 
levels of DRAM and DRAM2 mRNAs following p53 induction 
in TetOn-p53 cells (Fig. 2D). This revealed, in agreement with 
previous studies,19 that DRAM is strongly induced by p53 in this 
system (Fig. 2E). In contrast, no changes in DRAM2 mRNA were 
observed indicating that DRAM2 is not a transcriptional target 
of p53 (Fig. 2F). To test if DRAM2, like DRAM, was induced by 
TA-p73,24 Saos-2 cells were infected with an adenovirus expressing 
a transactivation-competent isoform of p73, TA-p73α (Fig. 2G). 
Also in agreement with previous studies, TA-p73α caused a marked 
increase in DRAM expression (Fig. 2H),24 however, similar to what 
was observed in TetOn-p53 cells, no increase in DRAM2 mRNA 
was seen following infection with TA-p73α (Fig. 2I).
Although DRAM2 was not responsive to p53 or p73, it 
remained possible that DRAM2 may still be a modulator of 
autophagy, perhaps in response to other stimuli. We first assessed, 
therefore, whether DRAM2, like DRAM, was a lysosomal 
protein.19 DRAM2 was induced in TetOn-DRAM2 cells for 24 h 
Figure 2. DRAM2, unlike DRAM is not induced by p53 or p73. (A–C) The specificity of qPCR primers for DRAM (B) and DRAM2 (C) were determined by 
analysis of TetOn-DRAM and TetOn-DRAM2 inducible cell lines (A). (D–F) p53 induces DRAM, but not DRAM2. TetOn-p53 inducible cells were treated 
with Dox for 24 h and the presence of p53 determined by western blotting (D). Expression levels of DRAM (E) and DRAM2 (F) mRNA in these TetOn-p53 
cells was determined by qPCR. (G–I) p73 induces DRAM, but not DRAM2. Saos-2 cells were infected with an adenovirus expressing TA-p73 or control 
“empty” adenovirus and expression of the p73 was determined by western blotting (G). Expression levels of DRAM (H) and DRAM2 (I) following infec-
tion of these cells with adenovirally-delivered TA-p73 was determined by qPCR. Dox, doxycycline.
www.landesbioscience.com Cell Cycle 2263
Regulation of autophagy by DRAM related proteins
Figure 3. DRAM2 is a lysosomal protein, but different from 
DRAM, DRAM2 does not regulate autophagy. (A) Tet-On DRAM2 
cells were induced with Dox for 24 h. Cells were then stained 
for DRAM2 (Myc) and for cathepsin D, stained with DAPI and 
analysed by fluorescent microscopy. (B) TetOn-DRAM and TetOn-
DRAM2 cells were infected with an adenovirus expressing GFP-
LC3 for 16 h. Cells were then induced with Dox for 24 h stained 
for DRAM or DRAM2 (Myc) and with DAPI and analysed by 
fluorescent microscopy. Dox, doxycycline.
either DRAM2 overexpression or DRAM2 knockdown 
during p53-induced autophagy had no effect on the rate of 
degradation observed (data not shown).
Drosophila only contain one DRAM protein which can 
modulate autophagy. Sequence homology searches using 
BLAST for DRAM polypeptides in other organisms revealed 
that many simpler organisms for example, Drosophila, 
contain only one obvious DRAM protein (Fig. 4A). 
This raises the question, therefore, as to whether human 
DRAM’s ability to modulate autophagy is an evolutionarily 
conserved process or whether DRAM has emerged later 
in evolution and that Drosophila DRAM (DmDRAM) is 
more like DRAM2. To test this, DmDRAM was expressed 
in cells and assessed for its ability to modulate autophagy 
(Fig. 4B). This clearly revealed that DmDRAM, like human 
DRAM, causes a marked increase in autophagosome 
number as judged by the appearance of GFP-LC3 puncta 
(Fig. 4C), indicating that the regulation of autophagy by 
DRAM proteins is an evolutionarily conserved process.
Although these studies provide clear insight into the 
evolutionary nature of DRAM-induced autophagy, perhaps 
the biggest question raised is what 
is the function of DRAM2? Despite 
having no role in autophagy it 
may be that DRAM2 shares some 
other function with DRAM. We 
have also previously shown that 
DRAM is critical for cell death 
downstream of p53, and while it 
is perceived that this is through 
DRAM’s ability to modulate 
autophagy, it remains formally 
possible that these two functions of 
DRAM are separable. Our studies, 
however, into the possibility that 
DRAM2 may regulate cell death 
indicates once again that DRAM2 
is different from DRAM. DRAM2 
appeared to have no effects on 
cell death when overexpressed and 
knockdown of DRAM2 by RNAi 
had no effect on cell death induced 
by p53 (data not shown).
Due to the extent of sequence 
homology between DRAM and 
DRAM2 it seems unlikely that the 
Figure 4. Drosophila DRAM can modulate autophagy. (A) Line-up of the peptide sequences of DRAM, DRAM2 
and DmDRAM. (B and C) Cells were transiently transfected with DmDRAM or empty vector as control. 24 h 
later cells were infected with an adenovirus expressing GFP-LC3. Following a further 24 h cells were either 
harvested for western blotting (B) or stained with DAPI and analysed by fluorescent microscopy (C).
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 previously described.30 Membranes were probed using  standard 
 immunoblotting techniques with antibodies that recognize 
HA-tagged p73 (HRP-conjugated HA, Roche), p53 (DO-1, 
Pharmingen), Myc-tagged DRAM, DRAM2 and Dm-DRAM 
(4A6, Upstate) and actin (clone 1A4, Sigma).
Immunofluorescence. For analysis of autophagosomes, cells 
were infected with an adenovirus expressing GFP-LC3 as described 
above. 16 h later cells were, where indicated, incubated either in 
the absence of presence of Dox. For transiently transfected cells, 
infection with adenovirally expressed GFP-LC3 where undertaken 
16 h hours after transfection. 24 h after infection with GFP-LC3, 
cells were fixed with 4% paraformaldehyde and permeabilized with 
0.3% triton. Cells were then stained with antibodies that recognize 
Myc-tagged DRAM proteins (4A6, Upstate). Following incuba-
tion with a Texas red conjugated secondary antibody (Molecular 
Probes Inc.,), cells were analyzed by confocal microsopy. For 
DRAM2 localization studies, cells were co-stained for Myc-tagged 
DRAM2 and for Cathepsin D (DAKO) as a lysosomal marker. In 
all immunofluorescence studies, cellular DNA was stained with 
4',6-diamidino-2-phenylindole (Sigma) prior to mounting and 
visualization.
Quantitative RT-PCR. RNA was prepared using TRIzol 
Reagent (Invitrogen). qPCR analysis was undertaken using the 
DyNAmo SYBR Green 2-step qRT-PCR kit (Finnzymes). Data 
collection was carried out using a Chromo4 real-time PCR 
detector and analysed with Opticon Monitor 3. Primers for 
DRAM and 18S have been previously described.19 Primers for 
DRAM2 were: (forward) AAG CAA GTT CAT GCT CTG AGT 
C, (reverse) CCA GAT AAC CAA CAA CAG TCT G. qPCR 
cycling parameters were 95°C 15 min [94°C 10 sec, 55°C 30 
sec, 72°C 30 sec] 34 cycles, 72°C 10 min. Expression levels of 
genes analysed by qPCR were normalized relative to levels of 18S 
rRNA.
Sequence alignments and phylogenetic analysis. Alignment of 
peptide sequences was undertaken using MultAlin (http://bioinfo.
genotoul.fr/multalin/multalin.html ).31 For phylogenetic analysis, 
sequences from NCBI were analyzed using Blast Tree View (http://
blast.ncbi.nlm.nih.gov)
Northerns. Northern analysis was undertaken as previ-
ously described.32 Briefly, 32P-labelled full-length cDNA probes 
were generated for DRAM2 and actin using RediPrime (GE 
Healthcare) as per the manufacturer’s instructions. Probes were 
then hybridized sequentially to a tissue Northern membrane 
(Clontech) as previously described33 Following 24 h of hybridiza-
tion, the membrane was washed 2 x 20 min in 2x SSC/0.1% SDS 
at room temperature, followed by 45 min in 0.1x SSC/0.1% SDS 
at 65°C and then subsequently exposed to X-Omat film (Kodak). 
Between sequential probings of the membrane, radioactive probe 
was stripped from the membrane by soaking in boiling 0.1% 
SDS followed by shaking at room temperature until ambient 
temperature was reached.
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two proteins are not in some way functionally related. It remains 
possible that since DRAM2 is constitutively expressed in many 
tissues, that induction of DRAM by p53 somehow perturbs the 
function of DRAM2 and thereby induces autophagy, or that the 
cell responds by inducing autophagy. In this regard, it would 
be interesting to know whether DRAM and DRAM2 interact 
within the cell. It seems clear too, that to understand DRAM2 
function it may be necessary first to understand the function of 
DRAM. Maybe the proteins do indeed have a similar function, 
but for example, have different substrates such that the effects 
they produce are markedly different. The generation of DRAM-
deficient animals—both mice and flies—would indeed be very 
rewarding and would yield information with respect to both 
the functional and evolutionary nature of DRAM function. For 
example, although DmDRAM can modulate autophagy, is this a 
functional aspect downstream of p53 in Drosophila? In this regard, 
it is important to note that Drosophila p53 is considered to be 
more like human p73 than human p53,27 and our previous studies 
have shown that while p73 induces DRAM, its ability to modulate 
autophagy is DRAM-independent.24 Ultimately, therefore, it is 
clear that many questions remain and that further investigation 
of not only DRAM and DRAM2, but the entire DRAM family 
should be highly rewarding.
Materials and Methods
Plasmids. pcDNA3-DRAM2-MycHis was generated by PCR 
from the I.M.A.G.E clone for TMEM77 Clone ID: 5491665 
using the following primers: (forward) ATA AGA TCT ATG TGG 
TGG TTT CAG CAA GGC CTC, (reverse) ATA TCT AGA 
AAT ATC TCT GGA AAG TAG CCG TGT. PCR products were 
digested with BglII and XbaI and cloned into the BamHI and 
XbaI sites of pcDNA3-MycHisA (Invitrogen). Similarly, pcDNA3-
DmDRAM-MycHis was amplified from Drosophila S2R+ RNA by 
RT-PCR using the following primers (forward) ATG CGA ATT 
CGC CAC CAT GTC ACA GGT TTA CTT GCT GCC G 
(reverse) CTG ACT CGA GAT GGT GGT CGA ATA GGA CAT 
CAG. Products were digested with EcoR1 and Xho1 and cloned 
into pcDNA3MycHisA (Invitrogen). pcDNA3-DRAM-MycHis 
has been previously described.19
Cell culture, transfections and infections. Saos2, HeLa and 
S2R+ cells can all be obtained from ATCC. TetOn-p53 and TetOn-
DRAM cells are Saos2 derived lines and have been previously 
described.19,28 All human cell lines were maintained in Dulbecco’s 
modified Eagle’s medium (Invitrogen) supplemented with 10% 
fetal bovine serum. Drosophila cells were maintained in Schneider’s 
medium (Invitrogen). Induction of transgene expression in Tet-On 
cell lines was achieved by addition of 1 μg/ml doxyclycline (Dox) 
(Sigma). Where indicated, cells were transfected by CaPO4 precip-
itation as previously described.29 Adenoviruses for TA-p73α and 
GFP-LC3 (a gift from Aviva Tolkovsky, Univeristy of Cambridge) 
were generated and purified as previously described24,25 and were 
added to cell cultures where indicated at a concentration of 12 
infectious units per cell.
Western blotting. Cells were lysed in a 2x western 
sample buffer and transferred to nitrocellulose membranes as 
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